TOP STORIES

• BUSINESS Takecab vs PPIs (3): Which Will Come Out on Top? Everything Now in the Hands of Frontline Prescribers
  March 13, 2015

• ORGANIZATION JSGM President Calls for Generic Share Target of 80% by FY2020
  March 12, 2015

• BUSINESS Takecab vs PPIs (2): Takecab to Initially Gain Share for H. pylori Eradication?
  March 12, 2015

• BUSINESS AZ to Tap Rich Pipelines to Grow as Oncology Powerhouse
  March 11, 2015

• BUSINESS Takecab vs PPIs (1): “Rapid, Sustained Efficacy” Pitted against “Patient Satisfaction”, Will Paradigm Shift Occur?
  March 11, 2015

• REGULATORY MHLW to Target 75% Generic Share for Welfare Recipients
  March 10, 2015

• ACADEMIA Interview on SGLT-2 Inhibitor Use (2): Prof. Watada Calls for Caution in Analyzing EPPV Data
  March 9, 2015

• ACADEMIA Interview on SGLT-2 Inhibitor Use (1): Prof. Ueki Says Flat Sales Reflect Cautious Prescribing by Physicians
  March 6, 2015

• BUSINESS Pfizer Japan Sales Down 5% as Generic Erosion Weighs
  March 5, 2015

• BUSINESS Weber to Become CEO of Takeda in April
  March 4, 2015

• REGULATORY Pharma Might Skirt Market-Price Based Price Cuts in 2017 If Physician Fees Become Taxable
  March 3, 2015

• BUSINESS Eli Lilly Aims to Lead Japan Diabetes Market by 2020
  March 2, 2015

• REGULATORY Novartis Slapped with 15 Day Biz Suspension over Flawed ADR Reporting
  February 27, 2015

• ACADEMIA Govt-Backed Research Center Looks to License Malaria Vaccine to Mega Pharma
  February 27, 2015

• REGULATORY MHLW OKs 60 New APIs in 2014, Doubling from Year Ago
  February 26, 2015

• BUSINESS Takeda to Acquire Turkish Firm for Up to 14.5 Billion Yen, Earn 13 Branded Generics
  February 25, 2015

• BUSINESS Daiichi Sankyo to Shake Up Japan Organization as Olmetec Patent Expiry Nears
  February 25, 2015

• REGULATORY Shelved Decision on Xarelto Recommendation Doesn’t Mean Disapproval: MHLW
  February 24, 2015

• BUSINESS Sun Pharma Wins Japan Approval for Cravit Generics, Competition with Daiichi Sankyo Might Arise
  February 23, 2015

• REGULATORY Gilead’s Sofosbuvir Could Join NHI Price List in May If OK’ed by PAFSC Panel on March 5
  February 20, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 191
• 192
• 193
• 194
• 195
• 196
• 197
• 198
• 199
• …
• Next ›
• 最終 »